Protalix biotherapeutics, inc. (PLX)
CashFlow / TTM
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-18,276

-24,001

-25,763

-26,482

-26,457

-34,328

-40,443

-31,531

-83,440

-72,759

-68,612

-79,915

-29,365

46,159

49,629

55,411

58,037

-23,332

-27,522

-28,570

-29,943

-32,359

-30,096

-30,814

-27,790

-26,782

-26,514

-10,035

-11,618

-10,654

-14,050

-37,381

-36,529

0

0

0

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-189

81,282

83,477

84,706

85,319

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-29,176

-35,123

-33,848

-29,295

-27,282

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments required to reconcile net loss to net cash used in operating activities:
Share based compensation

835

1,017

843

742

514

142

195

281

337

514

602

731

988

1,148

1,431

1,758

1,802

1,978

1,638

991

1,242

1,319

2,167

3,392

4,089

5,139

6,491

8,989

7,751

6,221

4,124

773

886

0

0

0

Depreciation

1,617

1,619

1,609

1,646

1,671

1,708

1,780

1,858

1,920

1,963

1,963

1,959

1,983

2,048

2,153

2,270

2,370

2,533

2,735

2,928

3,140

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and write down of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

3,705

3,690

3,683

3,631

0

0

0

Financial expenses (income), net (mainly exchange differences)

-378

-428

-76

-12

-20

90

2

3

40

-401

-236

-134

-13

353

-12

290

-124

-679

-1,524

-1,716

-1,446

-745

277

172

264

325

288

135

171

-208

-420

-172

-350

0

0

0

Changes in accrued liability for employee rights upon retirement

-10

119

116

82

-18

-158

-228

-184

-18

95

-8

9

10

12

203

106

59

7

1

86

140

204

209

190

200

203

236

292

276

258

211

166

155

0

0

0

Gain on amounts funded in respect of employee rights upon retirement

-

-

-

-

46

45

45

45

21

11

9

12

-7

13

8

-18

-18

-31

-26

22

22

57

69

40

58

0

0

0

-

-

-

-

-

-

-

-

Loss on extinguishment of convertible notes

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss (income) in connection with conversion of convertible notes

-

-

-

-

-

-

-

-

116

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of convertible notes embedded derivative

-

-

-

-

-

-

-

-

-38,061

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on amounts funded in respect of employee rights upon retirement

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Amortization of debt issuance costs and debt discount

2,991

2,883

2,780

2,687

2,602

2,540

2,450

2,363

2,334

1,945

1,488

1,048

568

445

445

445

445

445

445

445

444

444

347

236

127

0

0

0

-

-

-

-

-

-

-

-

Issuance of shares for interest payment in connection with conversions of convertible notes

-

-

-

-

234

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Increase (decrease) in contracts liability (including non-current portion)

-9,580

-3,081

17,397

17,375

17,880

43,279

23,131

23,108

24,178

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in deferred revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-398

114

181

362

7,527

5,376

3,968

886

0

0

0

-

869

620

946

1,281

-6,995

-6,700

-4,269

-3,005

0

0

0

Decrease (increase) in accounts receivable and other assets

-188

4,205

1,921

3,195

3,099

-2,831

426

395

-25

6,242

-281

3,010

1,133

-1,000

4,440

-111

-523

2,263

598

1,065

1,006

-2,458

-2,247

-1,536

-2,238

-1,544

-299

1,069

-243

1,018

-1,380

-6,815

-3,891

0

0

0

Changes in right of use assets

110

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Decrease (increase) in inventories

-414

-434

20

-312

736

480

-81

-81

2,588

2,619

992

1,363

-522

1,491

2,951

2,302

2,316

4,496

3,938

4,865

3,451

0

0

0

-

5,519

6,162

5,510

3,760

1,631

492

-838

-910

0

0

0

Increase (decrease) in accounts payable and accruals

2,735

5,949

1,998

1,112

-761

-5,601

-1,764

1,523

4,902

10,470

6,244

4,979

2,139

-17

40

-1,871

-1,873

1,614

547

1,345

1,367

4,546

4,097

3,424

869

-2,805

-2,199

214

2,977

2,128

3,505

3,344

6,147

0

0

0

Increase (decrease) in other long term liabilities

-482

-782

90

118

241

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in continuing operations

-

-

-

-

-

-

-

-

-

-35,038

-27,644

-31,367

-32,087

-32,744

-36,851

-28,871

-25,770

-22,483

-24,777

-26,942

-29,115

-22,493

-21,161

-22,751

-23,997

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by discontinued operations

-

-

-

-

-

-

-

-

-

116

-182

468

-11

4,127

3,017

1,383

1,486

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-19,358

-19,675

-2,811

-5,605

-7,742

13,852

-10,326

-10,981

-9,994

-34,922

-27,826

-30,899

-32,098

-28,617

-33,834

-27,488

-24,284

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

627

787

499

607

686

788

822

1,000

971

798

817

818

849

736

707

616

464

628

746

621

785

839

920

1,511

1,890

1,919

2,362

1,900

2,068

2,521

2,736

3,911

5,705

0

0

0

Decrease (increase) in restricted deposit

259

-55

12

-36

-62

57

-35

311

146

0

0

0

-

-

-

0

-

-

-

-

90

93

135

99

42

0

0

0

-

-

-

-

-

-

-

-

Amounts funded in respect of employee rights upon retirement, net

-3

96

99

63

-33

-133

-187

-144

5

107

31

30

32

33

165

138

96

71

51

87

137

171

200

173

170

166

165

143

138

136

132

161

165

0

0

0

Net cash used in continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,001

-1,103

-1,255

-1,783

-2,102

0

0

0

-

-

-

-

-

-

-

-

Net cash used in investing activities

-883

-828

-610

-634

-591

-709

-597

-1,164

-1,119

-1,327

-1,277

-957

-967

39,178

39,075

39,193

39,387

0

0

0

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Net payment for convertible notes

-

-

-

-

-

-

-

-

10,961

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of shares, net of issuance cost

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

25,328

25,328

25,478

25,508

20,650

0

0

0

Exercise of options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

46

125

113

143

112

164

174

1,194

1,230

1,110

1,104

57

277

0

0

0

Net cash used in financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

46

-25

66,893

66,923

66,892

0

0

0

-

-

-

-

-

-

-

-

Net cash used in financing activities

-

-

-

-

-

-

-

-

-1,419

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

225

77

190

35

-270

-5

-73

140

414

135

276

235

277

410

46

371

-131

-620

-1,483

-1,655

-1,395

-803

197

87

226

384

332

74

127

-331

-574

-254

-388

0

0

0

NET DECREASE IN CASH AND CASH EQUIVALENTS

-

-

-

-10,956

-

-

-

-6,698

-

-17,838

-20,093

-18,652

-13,093

17,072

11,388

18,711

21,607

-26,069

-27,906

-29,732

-31,631

-31,080

38,018

35,820

34,363

41,181

-26,154

-3,735

25,034

15,652

15,226

-4,622

-8,899

0

0

0

SUPPLEMENTARY INFORMATION ON INVESTING AND FINANCING ACTIVITIES NOT INVOLVING CASH FLOWS:
Purchase of property and equipment

98

2

312

11

225

97

275

232

526

619

432

911

595

985

1,024

615

489

144

71

176

120

121

52

-491

186

502

83

1,122

1,136

817

835

1,108

1,473

0

0

0

Convertible note conversions

-

-

-

-

2,285

10,831

14,897

16,733

16,263

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance cost related to convertible note offering not yet paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

150

120

60

0

0

0

Exercise of options granted to employees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

0

-

-

-

0

SUPPLEMENTARY DISCLOSURE ON CASH FLOWS
Interest paid

-

-

-

-

4,585

4,652

4,932

4,567

4,854

3,167

4,436

2,538

3,659

3,105

3,105

3,105

3,105

3,105

3,105

3,105

3,079

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-